BJU Int

1. VAN DEN EYNDE L, Ost P, Verla W, Everaerts W, et al
   Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer.
   BJU Int. 2025 Sep 20. doi: 10.1111/bju.70006.
   

   >> Share

   
   

   
   Br J Cancer

2. CHANG YH, Bresnahan ST, Taylor Head S, Harrison TA, et al
   Isoform-level analyses of 6 cancers uncover extensive genetic risk mechanisms undetected at the gene-level.
   Br J Cancer. 2025;133:874-885.
   

   >> Share

   
   

   
   Br J Radiol

3. LANDRY C, Klusa D, Cochonneau D, Supiot S, et al
   Circulating tumor cells for the prediction of the response to radiation therapy in prostate cancer.
   Br J Radiol. 2025 Sep 13:tqaf224. doi: 10.1093.
   

   >> Share

   
   

   
   Clin Imaging

4. DEFFLER C, Sedeh AE, Leitman E, Ng TSC, et al
   The role of PSMA PET/CT in identifying benign and malignant intracranial lesions in patients with prostate cancer.
   Clin Imaging. 2025 Sep 12:110620. doi: 10.1016/j.clinimag.2025.110620.
   

   >> Share

   
   

   
   Eur Urol

5. ENGLMAN C, Adebusoye B, Mallett S, Giganti F, et al
   Reply to Yuan Du, Dan Liu, and Zhihui Guan's Letter to the Editor re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Stu
   Eur Urol. 2025 Sep 18:S0302-2838(25)00500-7. doi: 10.1016/j.eururo.2025.
   

   >> Share

   
   

   
   Int J Urol

6. MIYOSHI Y, Uemura H, Ohta J, Kobayashi K, et al
   Prognostic Value of BONENAVI Computer-Aided Diagnosis System Bone Scans as an Imaging Biomarker for Bone-Metastatic Castration-Sensitive Prostate Cancer: An Investigator-Initiated, Multicenter, Prospective Observational Study.
   Int J Urol. 2025 Sep 23. doi: 10.1111/iju.70214.
   

   >> Share

   
   

   
   J Natl Cancer Inst

7. VERTOSICK EA, Vickers A, Dahlin A, Ulmert D, et al
   Prostate-specific antigen levels at age 60 and lifetime risk of lethal prostate cancer.
   J Natl Cancer Inst. 2025 Sep 19:djaf271. doi: 10.1093.
   

   >> Share

   
   

   
   Lancet Oncol

8. GRUBER K
   Prostate cancer screening bill before NZ Parliament.
   Lancet Oncol. 2025 Sep 18:S1470-2045(25)00557.
   

   >> Share

   
   

   
   Oncogene

9. SHENG H, Shi G, Lu Y, Zheng S, et al
   KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer.
   Oncogene. 2025 Sep 23. doi: 10.1038/s41388-025-03576.
   

   >> Share

   
   
10. GE Y, Han P, Sun Y, Chen Y, et al
    Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer.
    Oncogene. 2025 Sep 19. doi: 10.1038/s41388-025-03579.
    

    >> Share

    
    
11. CHUKHU M, Dahiya UR, Heemers HV
    Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer.
    Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03573.
    

    >> Share

    
    

    
    Oncol Rep

12. NAKAYAMA M, Takagi-Maeda S, Machino Y, Nihira K, et al
    Novel tetravalent bispecific antibody, PSMA/TRAIL?R2 REGULGENT, induces selective tumor cell apoptosis without hepatotoxicity.
    Oncol Rep. 2025;54:155.
    

    >> Share

    
    

    
    PLoS One

13. HWANG J, Kang BH, Park Y, Choi DH, et al
    Improving segmentation precision in prostate cancer adaptive radiation therapy with a patient-specific network.
    PLoS One. 2025;20:e0332603.
    

    >> Share

    
    
14. DAMKLIANG K, Thongsuksai P, Wongsirichot T, Kayasut K, et al
    Detection and score grading for prostate adenocarcinoma using semantic segmentation.
    PLoS One. 2025;20:e0331613.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

15. CHOWDHURY SR, Parikh CN, Kaur AN, DeMarco KD, et al
    PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.
    Proc Natl Acad Sci U S A. 2025;122:e2514948122.
    

    >> Share

    
    

    
    Prostate

16. HOGGARD NK, Berg FM, Szczepaniak MR, Wang X, et al
    Pathology of a Canine Model of Localized Prostate Carcinoma.
    Prostate. 2025 Sep 22. doi: 10.1002/pros.70054.
    

    >> Share

    
    
17. YANEZ-CASTILLO YM, Melgarejo-Segura MT, Arrabal-Polo MA, Jimenez-Pacheco A, et al
    Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI.
    Prostate. 2025 Sep 22. doi: 10.1002/pros.70055.
    

    >> Share

    
    
18. LI C, He C, Pan J, Feng Y, et al
    MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.
    Prostate. 2025 Sep 19. doi: 10.1002/pros.70053.
    

    >> Share

    
    
19. PEINADO BRR, Nazario RMF, Frazao DR, Ne YGS, et al
    Is There Any Association Between Periodontitis and Prostatic Alterations? A Systematic Review.
    Prostate. 2025;85:1369-1385.
    

    >> Share

    
    
20. SANDOVAL V, Osinski T, Malshy K, Feng C, et al
    Long-Term Oncological Outcomes of Robot-Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy.
    Prostate. 2025;85:1432-1439.
    

    >> Share

    
    
21. BORQUE-FERNANDO A, Guerrero-Ochoa P, Esteban LM, Hernandez A, et al
    Integration of Primary Care Into the Follow-Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region.
    Prostate. 2025 Sep 24. doi: 10.1002/pros.70057.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

22. GARG T, Wehrenberg-Klee E
    New Frontier for Prostate Artery Embolization: Neoadjuvant PAE before Radiation Therapy in Patients with Prostate Cancer.
    Radiol Imaging Cancer. 2025;7:e259023.
    

    >> Share

    
    
23. FIELDS BKK, Hassan OT
    An MRI Histopathology-based Deep Learning Approach for the Classification of Prostate Cancer.
    Radiol Imaging Cancer. 2025;7:e250466.
    

    >> Share

    
    
24. NGUYEN C, Hulsey G, James K, James T, et al
    Deep Learning Classification of Prostate Cancer Using MRI Histopathologic Data.
    Radiol Imaging Cancer. 2025;7:e240381.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share